All Comments by Nikolaos K. Robakis

  1. Modification of tau to an Alzheimer's type protein interferes with its interaction with microtubules.
  2. Soluble amyloid beta peptide concentration as a predictor of synaptic change in Alzheimer's disease.
  3. alpha-Synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with lewy bodies.
  4. Transgenic Drosophila expressing human amyloid precursor protein show gamma-secretase activity and a blistered-wing phenotype.
  5. Early amyloid deposition in the medial temporal lobe of young Down syndrome patients: a regional quantitative analysis.
  6. A familial case of Alzheimer's disease without tau pathology may be linked with chromosome 3 markers.
  7. Striation is the characteristic neuritic abnormality in Alzheimer disease.
  8. Assembly of paired helical filaments from mouse tau: implications for the neurofibrillary pathology in transgenic mouse models for Alzheimer's disease.
  9. Overexpression in neurons of human presenilin-1 or a presenilin-1 familial Alzheimer disease mutant does not enhance apoptosis.
  10. Genetic association of alpha2-macroglobulin with Alzheimer's disease in a Finnish elderly population.
  11. Interaction of Alzheimer beta-amyloid peptide(1-40) with lipid membranes.
  12. The Drosophila beta-amyloid precursor protein homolog promotes synapse differentiation at the neuromuscular junction.
  13. Presenilin-1 mutations downregulate the signalling pathway of the unfolded-protein response.
  14. Mutation-specific functional impairments in distinct tau isoforms of hereditary FTDP-17.
  15. An immunohistochemical study of centenarian brains: a comparison.